Neonatology Intensive Care Unit, University Hospital of Grenoble, CS 10217, 38043 Grenoble Cedex 9, France.
Neonatal Intensive Care Unit, University Hospital of Amiens, France-PériTox UMR_I 01, University of Picardy Jules Verne, 1, rond point du Professeur Christian Cabrol, 80054 Amiens, France.
Arch Pediatr. 2021 Jul;28(5):392-397. doi: 10.1016/j.arcped.2021.03.010. Epub 2021 Apr 30.
To investigate the characteristics and management of respiratory failure (RF) in moderate-to-late preterm infants.
NEOBS was a prospective, multicenter, observational study conducted in 46 neonatal intensive care units caring for preterm infants (30+ to 36+ weeks of gestation [WG]) in France in 2018. The cohort was stratified into two groups: 30-33 WG (group 1) and 34-36 WG (group 2). Infants with early neonatal RF were included and the outcomes assessed were maternal, pregnancy, and delivery characteristics and how RF was managed.
Of the 560 infants analyzed, 279 were in group 1 and 281 were in group 2. Most pregnancies were singleton (64.1%), and 67.4% of women received prenatal corticosteroids (mostly two doses). Infants were delivered by cesarean section in 59.6% of cases; 91.7% of the infants had an Apgar score ≥7 at 5min. More than 90% of infants were hospitalized post-birth (median duration, 36 and 15 days for groups 1 and 2, respectively). Medical intervention was required for 95.7% and 90.4% of the infants in group 1 and group 2, respectively, and included noninvasive ventilation (continuous positive airway pressure [CPAP]: 88.5% and 82.9%; high-flow nasal cannula: 55.0% and 44.7%, or other) and invasive ventilation (19.7% and 13.2%). The two main diagnoses of RF were respiratory distress syndrome (39.8%) and transient tachypnea of the newborn (57.3%). Surfactant was administered to 22.5% of the infants, using the less invasive surfactant administration (LISA) method for 34.4% of the patients. In the overall population, 8.6% of the infants had respiratory and/or hemodynamic complications.
The NEOBS study demonstrated that CPAP was widely used in the delivery room and the LISA method was chosen for 34.4% of the surfactant administrations for the management of RF in moderate-to-late preterm infants. The incidence of RF-related complications was low.
探讨中晚期早产儿呼吸衰竭(RF)的特点及管理。
NEOBS 是一项前瞻性、多中心、观察性研究,于 2018 年在法国 46 家新生儿重症监护病房对 30+至 36+ 周胎龄(WG)的早产儿进行。该队列分为两组:30-33 WG(组 1)和 34-36 WG(组 2)。纳入有早期新生儿 RF 的婴儿,评估的结局包括母亲、妊娠和分娩特征以及 RF 的管理方式。
在分析的 560 名婴儿中,279 名在组 1,281 名在组 2。大多数妊娠为单胎(64.1%),67.4%的女性接受产前皮质激素治疗(多为 2 剂)。剖宫产分娩占 59.6%;91.7%的婴儿在 5 分钟时 Apgar 评分为≥7 分。90%以上的婴儿出生后住院(中位数持续时间,组 1 为 36 天,组 2 为 15 天)。组 1 和组 2 中分别有 95.7%和 90.4%的婴儿需要医疗干预,包括无创通气(持续气道正压通气[CPAP]:88.5%和 82.9%;高流量鼻导管:55.0%和 44.7%,或其他)和有创通气(19.7%和 13.2%)。RF 的两个主要诊断为呼吸窘迫综合征(39.8%)和新生儿暂时性呼吸急促(57.3%)。22.5%的婴儿使用表面活性物质治疗,其中 34.4%的患者采用较少侵入性表面活性物质管理(LISA)方法。在总体人群中,8.6%的婴儿有呼吸和/或血流动力学并发症。
NEOBS 研究表明,CPAP 在产房广泛使用,LISA 方法用于 34.4%的表面活性物质治疗中晚期早产儿 RF。与 RF 相关的并发症发生率较低。